跳至主要内容
临床试验/NCT00204919
NCT00204919已完成不适用

Intermittent Vitamin D Administration in the Nursing Home: Impact on Vitamin D Status, Falls, Bone Turnover and Bone Density

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2001年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
96
试验地点
1
主要终点
Plasma 25-hydroxyvitamin D levels

研究概览

简要总结

Administration of vitamin D 50,000 units once monthly will:

  • Maintain serum 25-OH vitamin D above 20 ng/ml
  • Reduce falls
  • Increase calcaneal BMD
  • Reduce bone turnover
  • Be well tolerated: volunteers will not develop hypercalcemia
  • Improve performance on a swallowing quality of life questionnaire

详细描述

  1. Research questions: We propose a prospective double-blind, randomized, placebo-controlled trial of once-monthly vitamin D oral capsules (50,000 units) in nursing-home residents.

Subjects from several Wisconsin nursing homes were randomized to receive once-monthly vitamin D oral capsules (50,000 units) or placebo. Blood levels of 25-OH D, parathyroid hormone, serum calcium, and a marker of bone turnover will be measured periodically by standard lab assays. Swallowing quality of life was measured by questionnaire. Appropriate statistical tests (paired T tests, 95% confidence intervals will be calculated with the large sample approximation for binomial variables, other).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or Female
  • Nursing Home Resident in Wisconsin

排除标准

  • Renal Failure
  • Hypercalcemia
  • Metastatic Cancer

研究组 & 干预措施

1

Placebo Comparator

干预措施: placebo (Drug)

2

Active Comparator

干预措施: Vitamin D (Drug)

结局指标

主要结局

Plasma 25-hydroxyvitamin D levels

时间窗: 1 year

次要结局

  • Plasma calcium(one year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验